Alpa Laboratories Ltd (ALPA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 476646,
    "name": "Alpa Laboratorie",
    "stock_name": "Alpa Laboratorie",
    "full_name": "Alpa Laboratories Ltd",
    "name_url": "stocks-analysis/alpa-laboratorie",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "59.07",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "59.07",
    "mcapval": "128.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532878,
    "symbol": "ALPA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE385I01010",
    "curr_date": "Sep 24, 03:30 PM",
    "curr_time": "09:03 AM",
    "last_traded_at": "Sep 24, 03:30 PM IST",
    "bse_nse_vol": "1.37 lacs",
    "exc_status": "Active",
    "traded_date": "Sep 24, 2026",
    "traded_date_str": "2026 09 24",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alpa-laboratorie-476646-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4195026",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlpaLaboratorie_mojoScore_4195026.png",
        "date": "2026-09-16 10:10:19",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 September 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4177772",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/9/AlpaLaboratorie_mojoScore_4177772.png",
        "date": "2026-09-01 10:10:26",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-strong-sell-4163957",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_mojoScore_4163957.png",
        "date": "2026-08-21 10:10:24",
        "description": "Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Alpa Laboratories Ltd Valuation Shifts Signal Elevated Risk Amid Sector Challenges",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-valuation-shifts-signal-elevated-risk-amid-sector-challenges-4156935",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_valuationdot_4156935.png",
        "date": "2026-08-17 08:00:56",
        "description": "Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters deteriorate significantly, prompting a downgrade to a Strong Sell rating. With its price-to-earnings (P/E) ratio rising to 32.77 and price-to-book value (P/BV) at 0.71, the stock now appears riskier compared to its historical averages and peer group, reflecting growing investor caution amid underwhelming returns and sector headwinds."
      },
      {
        "title": "Are Alpa Laboratories Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-alpa-laboratories-ltd-latest-results-good-or-bad-4154715",
        "imagepath": "",
        "date": "2026-08-14 19:50:26",
        "description": "Alpa Laboratories Ltd's latest financial results for Q4 FY26 present a complex picture characterized by contrasting trends in profitability and revenue performance. The company reported a net profit of ₹1.38 crore, which reflects a sequential decline of 13.21% compared to the previous quarter. In terms of revenue, Alpa Laboratories generated ₹31.40 crore, marking an 8.09% increase from Q3 FY26 but a significant year-on-year decline of 21.34% from ₹39.92 crore in Q4 FY25. This revenue contraction is noteworthy as it follows a period of strong growth in the prior year, indicating potential challenges in sustaining sales momentum.\n\nDespite the revenue decline, the operating margin improved to 11.46%, the highest level in seven quarters, suggesting that the company has made strides in cost management. However, this margin expansion appears to be primarily driven by cost rationalization rather than an increase i..."
      },
      {
        "title": "Alpa Laboratories Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alpa-laboratories-ltd-reports-sharp-decline-in-quarterly-financial-performance-amid-negative-trend-shift-4153652",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_fintrenddot_4153652.png",
        "date": "2026-08-14 11:00:11",
        "description": "Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant deterioration in its recent quarterly financial performance. The company’s latest results for June 2026 reveal a marked decline in revenue, profitability, and key return metrics, signalling a shift from a previously flat to a negative financial trend. This downturn comes amid broader sector pressures and contrasts sharply with benchmark indices such as the Sensex."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4145264",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlpaLaboratorie_mojoScore_4145264.png",
        "date": "2026-08-10 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "When is the next results date for Alpa Laboratories Ltd?",
        "link": "https://www.marketsmojo.com/news/result-analysis/when-is-the-next-results-date-for-alpa-laboratories-ltd-4138681",
        "imagepath": "",
        "date": "2026-08-05 23:19:06",
        "description": "The next results date for Alpa Laboratories Ltd is scheduled for 14 August 2026...."
      },
      {
        "title": "Alpa Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alpa-laboratories-ltd-is-rated-sell-4128581",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlpaLaboratorie_mojoScore_4128581.png",
        "date": "2026-07-30 10:10:03",
        "description": "Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      }
    ],
    "total": 129,
    "sid": "476646",
    "stock_news_url": "https://www.marketsmojo.com/news/alpa-laboratories-476646"
  },
  "announcements": [
    {
      "details": "Alpa Laboratories Limited has informed the Exchange regarding 'Disclosure under Regulation 23(9) of SEBI (LODR) 2015 for the period ended 30th September, 2019.'.",
      "source": "NSE",
      "caption": "Alpa Laboratories Limited - Updates",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "Alpa Laboratories Limiteds Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Alpa Laboratories Limited - Clarification - Financial Results",
      "datetime": "14-Nov-2019"
    },
    {
      "details": " <table><tr><td>The Exchange had sought clarification from Alpa Laboratories Limited for the quarter ended 30-Jun-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted is not as per format prescribed by SEBI The response of the Company is enclosed. </td></tr></table>",
      "source": "NSE",
      "caption": "Reply to Clarification- Financial results",
      "datetime": "12-Sep-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alpa Laboratories Ltd is Rated Strong Sell

2026-09-16 10:10:19

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 16 September 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-09-01 10:10:26

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 September 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alpa Laboratories Ltd is Rated Strong Sell

2026-08-21 10:10:24

Alpa Laboratories Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 14 August 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 21 August 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Alpa Laboratories Ltd Valuation Shifts Signal Elevated Risk Amid Sector Challenges

2026-08-17 08:00:56

Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters deteriorate significantly, prompting a downgrade to a Strong Sell rating. With its price-to-earnings (P/E) ratio rising to 32.77 and price-to-book value (P/BV) at 0.71, the stock now appears riskier compared to its historical averages and peer group, reflecting growing investor caution amid underwhelming returns and sector headwinds.

Read full news article

Are Alpa Laboratories Ltd latest results good or bad?

2026-08-14 19:50:26

Alpa Laboratories Ltd's latest financial results for Q4 FY26 present a complex picture characterized by contrasting trends in profitability and revenue performance. The company reported a net profit of ₹1.38 crore, which reflects a sequential decline of 13.21% compared to the previous quarter. In terms of revenue, Alpa Laboratories generated ₹31.40 crore, marking an 8.09% increase from Q3 FY26 but a significant year-on-year decline of 21.34% from ₹39.92 crore in Q4 FY25. This revenue contraction is noteworthy as it follows a period of strong growth in the prior year, indicating potential challenges in sustaining sales momentum. Despite the revenue decline, the operating margin improved to 11.46%, the highest level in seven quarters, suggesting that the company has made strides in cost management. However, this margin expansion appears to be primarily driven by cost rationalization rather than an increase i...

Read full news article

Alpa Laboratories Ltd Reports Sharp Decline in Quarterly Financial Performance Amid Negative Trend Shift

2026-08-14 11:00:11

Alpa Laboratories Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a significant deterioration in its recent quarterly financial performance. The company’s latest results for June 2026 reveal a marked decline in revenue, profitability, and key return metrics, signalling a shift from a previously flat to a negative financial trend. This downturn comes amid broader sector pressures and contrasts sharply with benchmark indices such as the Sensex.

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-08-10 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 10 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

When is the next results date for Alpa Laboratories Ltd?

2026-08-05 23:19:06

The next results date for Alpa Laboratories Ltd is scheduled for 14 August 2026....

Read full news article

Alpa Laboratories Ltd is Rated Sell

2026-07-30 10:10:03

Alpa Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 30 May 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 30 July 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

View All News